Biotech

SBU joins elite HHS business-development task force

By GREGORY ZELLER // Stony Brook University will join an elite roster of national institutions in a new business-development feeder system devised by the U.S. Department of Health & Human Services. Introduced Tuesday as a business-accelerator program under the auspices of BARDA, HHS’s Biomedical Advanced Research and Development Authority, the nationwide network will foster development of new “health security” protocols – that is, preparedness to respond to threats ranging from chemical attacks and radiological terrorism…


Feinstein ‘risk index’ could get the jump on lupus

By GREGORY ZELLER // A complex research effort led by top Feinstein Institute scientists has opened the door to a wide range of early-intervention protocols for the dreaded disease lupus. A Feinstein Institute for Medical Research team led by immunologist and Professor Betty Diamond has developed a system for identifying a person’s risk for lupus by examining antibodies and a specific protein complex found in the blood. Ideally, scientists may use these unique markers to…


Envisagenics’ artificial intelligence wows real investors

By GREGORY ZELLER // They’re on a major roll at Envisagenics Inc., a Cold Spring Harbor Laboratory spinoff that’s piling up some hefty research grants. Now based in New York City, the biotech announced this week that it’s been awarded a $1.5 million Small Business Innovation Research Phase II grant from the National Institutes of Health – the second time the NIH has backed the data-crunching startup. The new award is earmarked for the continued…


How to speak cytokine: a bioelectronics breakthrough

By GREGORY ZELLER // You can bet they didn’t use secret decoder rings. In a major feat of bioengineering and neurological science, a team of doctors at Northwell Health’s Feinstein Institute for Medical Research has intercepted and decoded specific signals the human nervous system uses to communicate immune and inflammation status to the brain – a potentially ginormous forward leap for bioelectronic medicine. This latest bioelectronic breakthrough at what has become the international nerve center…


Grant backs NYU Winthrop’s out-of-the-skull thinking

By GREGORY ZELLER // A “surprise grant” from the Alzheimer’s Disease Resource Center will further some promising Alzheimer’s-related research underway at NYU Winthrop Hospital. The Mineola hospital’s Research Institute announced Wednesday that researcher Allison Reiss, head of the institute’s Inflammation Section, has received a $10,000 grant from ADRC – a Bay Shore-based advocacy group – to support her work with human stem cells. Reiss’ team – including NYU Winthrop researchers Aaron Pinkhasov, Irving Gomolin, Joshua…


Memo to Applied DNA: It’s payday in Pennsylvania

By GREGORY ZELLER // Memorandums of understanding are swell and all, but for a scrappy enterprise forever waging a bottom-line battle, nothing beats getting paid. So, Stony Brook-based Applied DNA Sciences should be very happy to receive the first of two “milestone payments” accompanying the March 31 signing of a new licensing deal with Pennsylvania manufacturer Colorcon Inc. Announced Thursday, the license and cooperation agreement grants Colorcon the exclusive worldwide right to add Applied DNA’s…


Applied DNA won’t let the bed thugs bite

By GREGORY ZELLER // You’ll sleep better knowing your gorgeous new bedding comes from 100 percent source-verified recycled plastic. So say global textiles manufacturer GHCL Ltd. and Applied DNA Sciences, the Stony Brook-based biotech that’s infusing its proprietary CertainT platform into the India-based conglomerate’s new Rekoop brand of bedding products. The CertainT molecular tagging and tracking technology will authenticate recycled plastics being spun into metaphorical gold: GHCL’s Rekoop line of bedsheets, pillowcases and shams, debuting…


Long-lasting glaucoma fix? They can see it from here

By GREGORY ZELLER // A Stony Brook biotech looking to carve a nanotech niche in the science of glaucoma treatment is eyeing some impressive laboratory results. Sustained Nano Systems, working closely with Stony Brook University’s Center for Biotechnology, has “achieved positive in-vitro results on long-term sustained delivery of Latanaprost for glaucoma treatment,” according to a company statement. Decoded: The biotech can keep the No. 1 glaucoma drug ticking for 159 days in in-vitro tests, which…


Applied DNA journeys deeper into India, and pharma

By GREGORY ZELLER // A new professional collaboration will deepen a Long Island biotech’s ties with global pharmaceutical and nutraceutical manufacturers. Stony Brook-based Applied DNA Sciences has signed a memorandum of understanding with India-based global pharmaceutical conglomerate ACG Worldwide, which is tapping into the Long Island firm’s molecular-based authentication services. The MoU – which is “expected to be followed by a definitive agreement,” according to Applied DNA – will apply the biotech’s SigNature molecular tagging…


NIH backs SBU-based biotech’s tuberculosis effort

By GREGORY ZELLER // A Setauket-based pharmaceuticals startup specializing in biomarker analysis has landed a chunky National Institutes of Health research award. Chronus Pharmaceuticals, founded and managed by researchers representing Stony Brook University and an assortment of other prestigious research institutions, announced this week that it has received a $299,172 Phase I Small Business Technology Transfer award from the NIH’s National Institute of Allergy and Infectious Diseases. The award, received in partnership with SBU’s Department…


Smoking-hot biotech sparks key cannabis contract

By GREGORY ZELLER // It’s another new high for Applied DNA Sciences. Just days after introducing a new satellite laboratory in India to service its growing Asian-Pacific customer base, the Stony Brook-based biotech lit up again Thursday, announcing a new contract to develop molecular tracking systems for a worldwide network of legal cannabis supplies. The two-year, $1 million development and marketing agreement with Canadian supplier TheraCann International Benchmark Corp. – which provides turn-key pharmaceutical solutions…


For Applied DNA, a lucrative new passage to India

By GREGORY ZELLER // Growing interest from Asian-Pacific textile manufacturers has prompted a Long Island biotech to establish a new testing laboratory in India. Stony Brook-based Applied DNA Sciences on Tuesday announced the opening of its new Central DNA Testing Laboratory in Ahmedabad, a city of 5.6 million residents in the Western India state of Gujarat, a manufacturing and distribution hub advancing cotton and other textiles, as well as fertilizers, petrochemicals and pharmaceuticals. From there,…


Applied DNA catches Irish robber blue/green-handed

By GREGORY ZELLER // Already the bane of Swedish car thieves, Applied DNA Sciences has now notched its first armed-robbery criminal conviction in Ireland. The latest international adventure for the Stony Brook-based anti-theft and product-authentication specialist and its ever-evolving roster of vertical markets takes us to the Emerald Isle, where evidence gathered through the biotech’s SigNature DNA platform has helped convict a thug involved in a violent theft. According to Applied DNA, the case involves…


Missiles, cars, leather … finally, biotech pushes pills

By GREGORY ZELLER // A biotech with a penchant for leather, foreign automobiles, high-tech weaponry and next-gen digital imaging is finally getting around to pharmaceuticals. Actually, that’s not true – Stony Brook-based Applied DNA Sciences has already this year announced multiple pharma-nutra-focused forays, including the production of DNA chains for in-vitro diagnostic and DNA-based therapeutic research purposes. But in announcing a technology license memorandum of understanding with Pennsylvania-based “hard dose” specialist Colorcon Inc., Applied DNA…


CSHL conference lands a bull’s eye on Lyme detection

By GREGORY ZELLER // A gaggle of academic, public health and commercial-healthcare specialists gathered under Cold Spring Harbor Laboratory’s mighty banner have published findings that could rewrite the book on Lyme disease detection. When the laboratory-diagnostics experts convened for a 2016 Banbury Center meeting – such gatherings, held at CSHL’s on-campus think tank, are generally regarded among the best international scientific workshops – they focused on Lyme, and specifically, earlier detection of a disease that…